V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014861 | 270010683 | null | null | Palliative (P) | 2013-09-05 | 2013-10-19 | Cyclophosphamide + Etoposide (PO) | N | N | 270024923 | ETOPOSIDE |
| 270014862 | 270019725 | 1.84 | 97.3 | Palliative (P) | null | 2014-03-26 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | null | null | 270024930 | ALEMTUZUMAB + FLUDARABINE + LEAM |
| 270014863 | 270019725 | null | null | Palliative (P) | 2018-01-13 | 2018-01-21 | ETOPOSIDE | 02 | N | 270024930 | ICE |
| 270014864 | 270010685 | 1.73 | 85.3 | Curative (C) | 2017-11-26 | 2017-11-27 | CHLVPP PABLOE | N | N | 270024984 | CVP R |
| 270014865 | 270010685 | 1.8 | 109.5 | Palliative (P) | 2018-03-10 | 2018-03-10 | ICE | 2 | N | 270024984 | LENALIDOMIDE |
| 270014866 | 270010685 | 1.68 | 79.5 | Palliative (P) | 2014-10-27 | 2014-11-08 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + MESNA + RITUXIMAB | N | N | 270024984 | GEMCARBO |
| 270014867 | 270010686 | 1.83 | null | Palliative (P) | 2015-05-20 | 2015-05-22 | Enzalutamide | 2 | null | 270025032 | CVD |
| 270014868 | 270010686 | 1.8 | null | Palliative (P) | 2015-12-21 | 2017-07-28 | VINCRISTINE | N | null | 270025032 | CHOP |
| 270014869 | 270010687 | 1.77 | 65.2 | null | 2018-03-07 | 2018-03-11 | CVP R | 02 | Y | 270025071 | BLEOMYCIN |
| 270014870 | 270010689 | 1.9 | 61 | Curative (C) | 2017-03-12 | 2017-05-15 | IGEV R | null | null | 270025074 | CHLVPP/PABLOE |
| 270014871 | 270010690 | 1.65 | 73.2 | Curative (C) | 2014-09-02 | 2014-09-18 | ICE | N | Y | 270025089 | DOCETAXEL |
| 270014872 | 270010691 | 1.52 | 0 | Palliative (P) | 2015-09-28 | 2015-09-30 | ECHELON 1 TRIAL | 02 | N | 270025094 | ICE |
| 270014873 | 270010692 | null | 64 | Palliative (P) | 2018-02-04 | 2018-02-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 270025100 | DOCETAXEL |
| 270014874 | 270010694 | 1.81 | 85 | Curative (C) | 2016-06-15 | 2016-06-15 | GEMCARBO | 02 | N | 270025100 | CARBO + FLUOROURACIL |
| 270014875 | 270014992 | 1.6 | 92.3 | Palliative (P) | 2014-09-26 | 2014-09-28 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270025111 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014876 | 270010696 | 1.74 | null | Palliative (P) | 2013-10-26 | 2013-10-26 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 270025117 | FLUOROURACIL + RT |
| 270014877 | 270010699 | 1.55 | 52.4 | null | 2018-06-20 | 2018-06-22 | CARBOPLATIN + RT | 02 | null | 270025122 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014878 | 270010700 | 1.66 | 82.4 | Not known (9) | 2016-06-08 | 2016-06-16 | Vinorelbine (oral) | null | null | 270025137 | DOCETAXEL |
| 270014879 | 270018562 | 1.53 | 140.4 | Curative (C) | 2014-05-09 | 2014-05-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | 270025137 | AXITINIB |
| 270014880 | 270018562 | 1.54 | 83.3 | Not known (9) | 2015-03-02 | 2015-03-02 | Cyclophosphamide+Fludara+TBI Allo | 2 | Y | 270025137 | RATHL TRIAL |
| 270014881 | 270010702 | 1.56 | 67.6 | Palliative (P) | 2016-01-15 | 2016-01-15 | CARBOPLATIN + RT | N | N | 270025142 | CARBOPLATIN + RT |
| 270014882 | 270018563 | 1.88 | 86.9 | Disease modification (D) | 2016-05-08 | 2016-05-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270025145 | IRINOTECAN + RALTITREXED |
| 270014883 | 270010703 | 1.73 | null | Palliative (P) | 2014-07-13 | 2014-07-15 | Bevacizumab + Irinotecan + MdG | N | N | 270025181 | DOCETAXEL |
| 270014884 | 270014995 | 1.82 | 116.4 | Curative (C) | 2014-12-23 | 2014-12-25 | CARBOPLATIN + RT | N | Y | 270025188 | CARBOPLATIN + RT |
| 270014885 | 270014995 | 1.6 | 78.5 | null | 2014-05-21 | 2014-07-08 | FLUOROURACIL + MITOMYCIN + RT | 99 | null | 270025188 | CETUXIMAB + CISPLATIN + FU |
| 270014886 | 270010705 | 1.6 | 56 | Palliative (P) | 2016-01-20 | 2016-03-22 | Docetaxel 75mg/m2 (21 day) | N | N | 270025217 | CARBOPLATIN + IRINOTECAN |
| 270014887 | 270010705 | 1.84 | 94 | Curative (C) | null | 2014-10-29 | PACLITAXEL | N | N | 270025217 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014888 | 270010706 | 1.78 | 74.8 | Curative (C) | 2013-12-21 | 2014-01-05 | FOXTROT TRIAL | 02 | N | 270025241 | SCOT TRIAL |
| 270014889 | 270010707 | 1.82 | 79.2 | Palliative (P) | 2016-11-17 | 2016-11-17 | PMitCEBO | 2 | N | 270025260 | RUXOLITINIB |
| 270014890 | 270010708 | 1.65 | 77.5 | null | 2014-12-19 | 2014-12-24 | Capecitabine + Mitomycin | 2 | N | 270025267 | CAV |
| 270014891 | 270014997 | null | 98 | null | 2015-12-02 | 2015-12-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270025272 | PEMBROLIZUMAB |
| 270014892 | 270018565 | 1.75 | 59.2 | Palliative (P) | 2017-12-25 | 2017-12-26 | IBRUTINIB | N | N | 270025294 | CARBOPLATIN + RT |
| 270014893 | 270017276 | null | 81.7 | Disease modification (D) | 2018-01-14 | 2018-01-23 | Abiraterone | N | N | 270025305 | DOCETAXEL |
| 270014894 | 270010710 | 1.76 | 53 | Disease modification (D) | 2014-04-05 | 2014-04-11 | CARBOPLATIN + RT | N | N | 270025336 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270014895 | 270014999 | 1.7 | 128.2 | Disease modification (D) | 2014-02-12 | 2014-02-27 | Thalidomide 50mg | N | N | 270025344 | LENALIDOMIDE |
| 270014896 | 270010711 | null | 57 | Palliative (P) | 2013-06-08 | 2014-10-22 | IRINOTECAN + MDG + PANITUMUMAB | N | N | 270025364 | CETUXIMAB + MDG |
| 270014897 | 270010711 | 1.75 | 67 | Curative (C) | 2013-05-15 | 2013-05-15 | OXALIPLATIN | 2 | N | 270025364 | PACLITAXEL |
| 270014898 | 270010713 | 1.75 | null | Palliative (P) | 2014-05-25 | 2014-05-28 | CARBOPLATIN + RT | N | null | 270025433 | CETUXIMAB + CISPLATIN + FU |
| 270014899 | 270017278 | 1.63 | 54.2 | Palliative (P) | 2018-02-01 | 2018-03-15 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 270025433 | GEMCARBO |
| 270014900 | 270017278 | 1.94 | 94.5 | Palliative (P) | 2018-03-13 | 2018-03-21 | MITOMYCIN | 02 | N | 270025433 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270014901 | 270010715 | 1.79 | 85 | Palliative (P) | 2017-02-08 | 2017-04-16 | PEMBROLIZUMAB | N | N | 270025495 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014902 | 270010716 | 1.57 | 88.1 | Palliative (P) | 2019-03-05 | 2019-03-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270025562 | CISPLATIN + PEMETREXED |
| 270014903 | 270010717 | 1.8 | 79.5 | Not known (9) | 2013-05-05 | 2013-05-09 | IBRUTINIB | N | N | 270025563 | IBRUTINIB |
| 270014904 | 270010718 | 1.77 | 57 | Palliative (P) | null | 2016-08-09 | CETUXIMAB + OXALIPLATIN | Y | N | 270025622 | CETUXIMAB + MDG |
| 270014905 | 270010719 | 1.65 | 83.2 | Palliative (P) | 2014-05-16 | 2014-05-24 | Pazopanib | N | N | 270025622 | CARBOPLATIN + RT |
| 270014906 | 270010720 | 1.6 | 50.8 | Palliative (P) | 2016-05-02 | 2016-07-26 | CAP + RT | N | N | 270025682 | CARBOPLATIN + RT |
| 270014907 | 270010721 | null | 74.8 | Palliative (P) | null | 2015-11-05 | Carbo F | N | N | 270025707 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270014908 | 270010722 | 1.59 | 81 | Curative (C) | 2014-04-01 | 2014-04-01 | ECHELON 1 TRIAL | 02 | N | 270025707 | BLEOMYCIN |
| 270014909 | 270010722 | 1.63 | 52 | Palliative (P) | 2017-09-23 | 2017-10-21 | CARBOPLATIN + RT | Y | N | 270025707 | HYDROXYCARBAMIDE |
| 270014910 | 270010723 | 1.83 | 102.9 | Curative (C) | 2017-07-10 | 2017-08-07 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270025740 | BEVACIZUMAB + CAPE + IRINOTECAN |